News | November 17, 2008

China Sky One Medical, Inc. Obtains Production Rights For Nine New Drugs

China Sky One Medical, Inc. ("China Sky One Medical" or "the Company"), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), announced recently that it successfully obtained the rights to nine new drugs under an agreement its subsidiary, Peng Lai Jin Chuang Company Pharmaceutical Company ("Jin Chuang"), signed with Shandong Medicine Research & Development Institute.

Under the terms of the agreement, China Sky One obtained all rights to nine new drugs in consideration for a cash payment of RMB 15 million (US $2.2M; 1 RMB = $0.14 US dollars). Popular in the rural areas of China, the nine new drugs have passed all clinical trials required by the State Food and Drug Administration (SFDA) in China, and have also been approved by the SFDA for production and sale.

  • Oyster Shell Calcium Granules and Oyster Shell Calcium Tablets: for the treatment of calcifames and osteoporosis, especially for children, the elderly and pregnant and nursing women;
  • Loquat Syrup: an expectorant for the treatment of tussis and bronchitis;
  • Flos Lonicerae Syrup: for the treatment coughs, colds, fever and sore throat;
  • Sedative Bolus: for the treatment of depression and insomnia;
  • Compound Paracetamol and Diphenhydramine Hydrochloride Tablets: for the treatment of fever, headaches and perennial allergic rhinitis;
  • Compound Tablet of Red Sage Root: for activating blood circulation to dissipate blood stasis and angina;
  • Compound Aminopyrine Tablets: for the treatment of fever and mild or moderate pain
  • Vitamin B1 Tablets: as a supplement to prevent certain illness, such as beriberi and dyspepsia.

"We are very excited about these nine new drugs, which complement our product portfolio nicely. We estimate that revenue from them will reach USD $5.0M in 2009," said Mr. Yan-Qing Liu, Chairman, CEO and President of China Sky One Medical. "As part of our strategy, we will continue to look for opportunities to add suitable pharmaceuticals to our portfolio to enhance and expand our product line."

About China Sky One Medical, Inc.
China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio- Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Company Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.skyonemedical.com/ .

SOURCE:China Sky One Medical, Inc.